AgingResearch.NewsJoin free

Transforming growth factor-beta

Biomarker

3 papers1 finding

  • Animals2
  • Cells1

Interventions

1

Human dermal fibroblast-conditioned medium and electromagnetic transduction therapy

downin human cells1

1 study

  1. Human dermal fibroblast-conditioned medium and electromagnetic transduction therapy decreases transforming growth factor-beta in human cells.

    “Moreover, interleukin-6 was upregulated and transforming growth factor-β was downregulated by HDFCM and EMTT treatments.”

    Cellsdermal fibroblast

    Effect of Dermal Fibroblast-Conditioned Media on Human Dermal Fibroblasts Treated With Electromagnetic Transduction Therapy

    Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)1 Oct 2026

More on Human dermal fibroblast-conditioned medium and electromagnetic transduction therapy

Latest

Nov 2025: 1Dec 2025: 1Jan 2026: 2Feb 2026: 2Mar 2026: 2Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 2Oct 2026: 212 in 12 months
Nature Immunology

Clonal hematopoiesis remodels human bone marrow into an inflammatory prefibrotic environment

Single-cell and spatial profiling revealed expanded fibroblasts and localized hubs of inflammation driven by tumor necrosis factor and transforming growth factor-beta…Single-cell and spatial profiling revealed expanded fibroblasts and localized hubs of inflammation driven by tumor necrosis factor and transforming growth factor-beta signaling.

Cross-sectional study in peopleExtracellular matrix remodelling
Paper

Related